Search

Fred E Cooperrider

Examiner (ID: 11124)

Most Active Art Unit
2723
Art Unit(s)
2723, 2623
Total Applications
39
Issued Applications
33
Pending Applications
2
Abandoned Applications
4

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6388959 [patent_doc_number] => 20100317718 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-16 [patent_title] => 'MODULATION OF HIF1 BETA EXPRESSION' [patent_app_type] => utility [patent_app_number] => 12/846746 [patent_app_country] => US [patent_app_date] => 2010-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30367 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20100317718.pdf [firstpage_image] =>[orig_patent_app_number] => 12846746 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/846746
MODULATION OF HIF1 BETA EXPRESSION Jul 28, 2010 Abandoned
Array ( [id] => 6622742 [patent_doc_number] => 20100311082 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'Stable Cell Lines and Methods for Evaluating Gastrointestinal Absorption of Chemicals' [patent_app_type] => utility [patent_app_number] => 12/843706 [patent_app_country] => US [patent_app_date] => 2010-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 25992 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20100311082.pdf [firstpage_image] =>[orig_patent_app_number] => 12843706 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/843706
Stable cell lines and methods for evaluating gastrointestinal absorption of chemicals Jul 25, 2010 Issued
Array ( [id] => 6383306 [patent_doc_number] => 20100317049 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-16 [patent_title] => 'Stable Cell Lines and Methods for Evaluating Gastrointestinal Absorption of Chemicals' [patent_app_type] => utility [patent_app_number] => 12/843536 [patent_app_country] => US [patent_app_date] => 2010-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 25990 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20100317049.pdf [firstpage_image] =>[orig_patent_app_number] => 12843536 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/843536
Stable cell lines and methods for evaluating gastrointestinal absorption of chemicals Jul 25, 2010 Issued
Array ( [id] => 8359726 [patent_doc_number] => 20120214862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-23 [patent_title] => 'MODULATION OF FACTOR 7 EXPRESSION' [patent_app_type] => utility [patent_app_number] => 13/384327 [patent_app_country] => US [patent_app_date] => 2010-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36797 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13384327 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/384327
MODULATION OF FACTOR 7 EXPRESSION Jul 14, 2010 Abandoned
Array ( [id] => 8187560 [patent_doc_number] => 20120116360 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-10 [patent_title] => 'TREATMENT OF NEUROLOGICAL DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/383560 [patent_app_country] => US [patent_app_date] => 2010-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 16208 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20120116360.pdf [firstpage_image] =>[orig_patent_app_number] => 13383560 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/383560
Treatment of neurological disorders Jul 14, 2010 Issued
Array ( [id] => 10831345 [patent_doc_number] => 08859515 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-14 [patent_title] => 'Treatment of tumor necrosis factor receptor 2 (TNFR2) related diseases by inhibition of natural antisense transcript to TNFR2' [patent_app_type] => utility [patent_app_number] => 13/379728 [patent_app_country] => US [patent_app_date] => 2010-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 25535 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13379728 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/379728
Treatment of tumor necrosis factor receptor 2 (TNFR2) related diseases by inhibition of natural antisense transcript to TNFR2 Jun 23, 2010 Issued
Array ( [id] => 10077562 [patent_doc_number] => 09115404 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-25 [patent_title] => 'Polynucleotides for medical use' [patent_app_type] => utility [patent_app_number] => 13/379084 [patent_app_country] => US [patent_app_date] => 2010-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 52 [patent_no_of_words] => 24003 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13379084 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/379084
Polynucleotides for medical use Jun 20, 2010 Issued
Array ( [id] => 8313711 [patent_doc_number] => 20120190728 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-26 [patent_title] => 'COMPOSITIONS AND METHODS FOR MODULATION OF SMN2 SPLICING IN A SUBJECT' [patent_app_type] => utility [patent_app_number] => 13/380021 [patent_app_country] => US [patent_app_date] => 2010-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 24574 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13380021 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/380021
Compositions and methods for modulation of SMN2 splicing in a subject Jun 16, 2010 Issued
Array ( [id] => 8265974 [patent_doc_number] => 20120165401 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-28 [patent_title] => 'APTAMER FOR CHYMASE, AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/377201 [patent_app_country] => US [patent_app_date] => 2010-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 24021 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13377201 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/377201
Aptamer for chymase, and use thereof Jun 10, 2010 Issued
Array ( [id] => 8976084 [patent_doc_number] => 20130209514 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-15 [patent_title] => 'APTAMER-TARGETED COSTIMULATORY LIGAND APTAMER' [patent_app_type] => utility [patent_app_number] => 13/376873 [patent_app_country] => US [patent_app_date] => 2010-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 24612 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13376873 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/376873
APTAMER-TARGETED COSTIMULATORY LIGAND APTAMER Jun 2, 2010 Abandoned
Array ( [id] => 8555197 [patent_doc_number] => 08329670 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-11 [patent_title] => 'System for delivering nucleic acids for suppressing target gene expression by utilizing endogenous chylomicron' [patent_app_type] => utility [patent_app_number] => 12/787552 [patent_app_country] => US [patent_app_date] => 2010-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 12284 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12787552 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/787552
System for delivering nucleic acids for suppressing target gene expression by utilizing endogenous chylomicron May 25, 2010 Issued
Array ( [id] => 8265964 [patent_doc_number] => 20120165391 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-28 [patent_title] => 'USE OF INHIBITORS OF ZDHHC2 ACTIVITY FOR MODULATION OF ADIPOGENESIS' [patent_app_type] => utility [patent_app_number] => 13/321013 [patent_app_country] => US [patent_app_date] => 2010-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6299 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13321013 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/321013
Use of inhibitors of Zdhhc2 activity for modulation of adipogenesis May 18, 2010 Issued
Array ( [id] => 6148705 [patent_doc_number] => 20110020300 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF GLUCOCORTICOID RECEPTOR (GCR) GENES' [patent_app_type] => utility [patent_app_number] => 12/780813 [patent_app_country] => US [patent_app_date] => 2010-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 27630 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20110020300.pdf [firstpage_image] =>[orig_patent_app_number] => 12780813 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/780813
COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF GLUCOCORTICOID RECEPTOR (GCR) GENES May 13, 2010 Abandoned
Array ( [id] => 6388936 [patent_doc_number] => 20100317716 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-16 [patent_title] => 'RNA INTERFERENCE MEDIATED INHIBITION OF TNF AND TNF RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)' [patent_app_type] => utility [patent_app_number] => 12/777816 [patent_app_country] => US [patent_app_date] => 2010-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 66119 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20100317716.pdf [firstpage_image] =>[orig_patent_app_number] => 12777816 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/777816
RNA interference mediated inhibition of TNF and TNF receptor gene expression using short interfering nucleic acid (siNA) May 10, 2010 Issued
Array ( [id] => 5993598 [patent_doc_number] => 20110015251 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-20 [patent_title] => 'RNA INTERFERENCE MEDIATED INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)' [patent_app_type] => utility [patent_app_number] => 12/777767 [patent_app_country] => US [patent_app_date] => 2010-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 69856 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20110015251.pdf [firstpage_image] =>[orig_patent_app_number] => 12777767 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/777767
RNA interference mediated inhibition of human immunodeficiency virus (HIV) gene expression using short interfering nucleic acid (siNA) May 10, 2010 Issued
Array ( [id] => 6388949 [patent_doc_number] => 20100317717 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-16 [patent_title] => 'RNA INTERFERENCE MEDIATED INHIBITION OF PLATELET DERIVED GROWTH FACTOR (PDGF) AND PLATELET DERIVED GROWTH FACTOR RECEPTOR (PDGFR) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)' [patent_app_type] => utility [patent_app_number] => 12/777913 [patent_app_country] => US [patent_app_date] => 2010-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 68181 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20100317717.pdf [firstpage_image] =>[orig_patent_app_number] => 12777913 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/777913
RNA interference mediated inhibition of platelet derived growth factor (PDGF) and platelet derived growth factor receptor (PDGFR) gene expression using short interfering nucleic acid (siNA) May 10, 2010 Issued
Array ( [id] => 7490667 [patent_doc_number] => 20110237643 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'Identification of a Novel repressor on IFN-lambda promoter and siRNA against ZEB1 and BLIMP-1 to increase IFN-lambda gene activity' [patent_app_type] => utility [patent_app_number] => 12/799925 [patent_app_country] => US [patent_app_date] => 2010-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 16277 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20110237643.pdf [firstpage_image] =>[orig_patent_app_number] => 12799925 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/799925
Identification of a novel repressor on IFN-lambda promoter and siRNA against ZEB1 and BLIMP-1 to increase IFN-lambda gene activity May 4, 2010 Issued
Array ( [id] => 7774256 [patent_doc_number] => 08119612 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-21 [patent_title] => 'RNAi inhibition of alpha-ENaC expression' [patent_app_type] => utility [patent_app_number] => 12/771566 [patent_app_country] => US [patent_app_date] => 2010-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 38409 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/119/08119612.pdf [firstpage_image] =>[orig_patent_app_number] => 12771566 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/771566
RNAi inhibition of alpha-ENaC expression Apr 29, 2010 Issued
Array ( [id] => 6506141 [patent_doc_number] => 20100210514 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'RNAi Inhibition of Alpha-ENaC Expression' [patent_app_type] => utility [patent_app_number] => 12/771614 [patent_app_country] => US [patent_app_date] => 2010-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 38431 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20100210514.pdf [firstpage_image] =>[orig_patent_app_number] => 12771614 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/771614
RNAi inhibition of alpha-ENaC expression Apr 29, 2010 Issued
Array ( [id] => 4469963 [patent_doc_number] => 07943592 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-17 [patent_title] => 'RNAi inhibition of alpha-ENaC expression' [patent_app_type] => utility [patent_app_number] => 12/771470 [patent_app_country] => US [patent_app_date] => 2010-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 38434 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/943/07943592.pdf [firstpage_image] =>[orig_patent_app_number] => 12771470 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/771470
RNAi inhibition of alpha-ENaC expression Apr 29, 2010 Issued
Menu